These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 24036549)
21. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma. Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656 [TBL] [Abstract][Full Text] [Related]
22. Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program. Leontieva OV; Demidenko ZN; Blagosklonny MV Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8832-7. PubMed ID: 24889617 [TBL] [Abstract][Full Text] [Related]
23. Differentiation-inducing factor-1 suppresses cyclin D1-induced cell proliferation of MCF-7 breast cancer cells by inhibiting S6K-mediated signal transducer and activator of transcription 3 synthesis. Tetsuo F; Arioka M; Miura K; Kai M; Kubo M; Igawa K; Tomooka K; Takahashi-Yanaga F; Nishimura F; Sasaguri T Cancer Sci; 2019 Dec; 110(12):3761-3772. PubMed ID: 31553107 [TBL] [Abstract][Full Text] [Related]
25. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway. Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894 [TBL] [Abstract][Full Text] [Related]
26. L-threonine regulates G1/S phase transition of mouse embryonic stem cells via PI3K/Akt, MAPKs, and mTORC pathways. Ryu JM; Han HJ J Biol Chem; 2011 Jul; 286(27):23667-78. PubMed ID: 21550972 [TBL] [Abstract][Full Text] [Related]
27. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563 [TBL] [Abstract][Full Text] [Related]
28. Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib. Porcelli L; Mazzotta A; Garofoli M; Di Fonte R; Guida G; Guida M; Tommasi S; Azzariti A Biomed Pharmacother; 2021 Jan; 133():111006. PubMed ID: 33202284 [TBL] [Abstract][Full Text] [Related]
29. Mechanism of ribosomal p70S6 kinase activation by granulocyte macrophage colony-stimulating factor in neutrophils: cooperation of a MEK-related, THR421/SER424 kinase and a rapamycin-sensitive, m-TOR-related THR389 kinase. Lehman JA; Calvo V; Gomez-Cambronero J J Biol Chem; 2003 Jul; 278(30):28130-8. PubMed ID: 12740386 [TBL] [Abstract][Full Text] [Related]
30. Phosphatidylinositol-3 kinase/Akt/p70S6K/AP-1 signaling pathway mediated benzo(a)pyrene-induced cell cycle alternation via cell cycle regulatory proteins in human embryo lung fibroblasts. Gao A; Liu B; Shi X; Jia X; Ye M; Jiao S; You B; Huang C Toxicol Lett; 2007 Apr; 170(1):30-41. PubMed ID: 17383120 [TBL] [Abstract][Full Text] [Related]
31. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells. Bessard A; Frémin C; Ezan F; Coutant A; Baffet G J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199 [TBL] [Abstract][Full Text] [Related]
32. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB. Varma S; Khandelwal RL Biochim Biophys Acta; 2007 Jan; 1770(1):71-8. PubMed ID: 16952420 [TBL] [Abstract][Full Text] [Related]
33. Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin D1, cyclin A, and proliferating cell nuclear antigen. Law BK; Waltner-Law ME; Entingh AJ; Chytil A; Aakre ME; Nørgaard P; Moses HL J Biol Chem; 2000 Dec; 275(49):38261-7. PubMed ID: 10993886 [TBL] [Abstract][Full Text] [Related]
34. Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence. Demidenko ZN; Shtutman M; Blagosklonny MV Cell Cycle; 2009 Jun; 8(12):1896-900. PubMed ID: 19478560 [TBL] [Abstract][Full Text] [Related]
35. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence. Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870 [TBL] [Abstract][Full Text] [Related]
36. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354 [TBL] [Abstract][Full Text] [Related]
37. Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107. Khor ES; Wong PF Int J Biochem Cell Biol; 2018 Aug; 101():64-73. PubMed ID: 29857052 [TBL] [Abstract][Full Text] [Related]
38. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067 [TBL] [Abstract][Full Text] [Related]
39. 1,8-Cineole promotes G0/G1 cell cycle arrest and oxidative stress-induced senescence in HepG2 cells and sensitizes cells to anti-senescence drugs. Rodenak-Kladniew B; Castro A; Stärkel P; Galle M; Crespo R Life Sci; 2020 Feb; 243():117271. PubMed ID: 31926243 [TBL] [Abstract][Full Text] [Related]
40. MEK1/2 overactivation can promote growth arrest by mediating ERK1/2-dependent phosphorylation of p70S6K. Guégan JP; Ezan F; Gailhouste L; Langouët S; Baffet G J Cell Physiol; 2014 Jul; 229(7):903-15. PubMed ID: 24501087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]